secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-10-08T21:15:13+00:00
Accession:  0001193125-26-418065
Event type: debt
Sentiment:  negative
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

FibroBiologics raises $1.02M via $1.2M convertible debenture to Peak One; 15% OID, 0% interest
--------------------------------------------------------------------------------

- Issued $1.2M principal convertible debenture to Peak One Opportunity Fund for $1,020,000 cash, a 15% original issue discount, plus 125,000 restricted commitment shares and a $20,000 fee.
- Debenture matures Oct 8, 2027, pays 0% interest, and is convertible at $0.78/share only after an Event of Default; default allows 18% interest and 120% acceleration.
- Company must pay $1,080,000 on Apr 8, 2027, $60,000 on Jul 8, 2027, and $60,000 or remaining balance at maturity; holder can require 50% of cash proceeds over $1.5M be used to repay.
- Exchange cap limits issuance to 1,671,094 shares absent stockholder approval; 4.99% beneficial ownership blocker applies; no variable-rate transactions while debenture outstanding.
- Company may redeem at 100% principal anytime no Event of Default; proceeds solely for business operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526418065/0001193125-26-418065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526418065/fblg-20261007.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-418065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer